Literature DB >> 5497891

Intracellular development of bacteriophage phi-R. II. Fractionation of replicative form deoxyribonucleic acid associated with rapidly sedimenting host cell components.

A J Burton.   

Abstract

When Escherichia coli is infected with bacteriophage phiR, parental deoxyribonucleic acid (the single- or double-stranded DNA containing the isotopic label of the infecting phage) becomes firmly attached to a cellular structure and can be isolated as a rapidly sedimenting component as described earlier for phiX174. If this component is centrifuged to equilibrium, two peaks of infective DNA are observed at densities of 1.30 and 1.15 g/ml. At low multiplicities of infection, (32)P-labeled parental DNA is found associated with only the cellular components in the dense band; as the multiplicities of infection are increased, the dense band becomes saturated and parental DNA molecules are then found at the light density as well. Actively replicating host DNA is found only in the dense band, whereas progeny DNA, which does not replicate semiconservatively, can become associated with cellular components in the light band. This fractionation of cellular components on the basis of their buoyant density separates primary sites of DNA replication associated with the dense band from nonfunctional binding sites in the light band.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5497891      PMCID: PMC376143     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  The process of infection with bacteriophage phiX174. XXV. Studies with bacteriophage phiX174 mutants blocked in progeny replicative form DNA synthesis.

Authors:  A J Levine; R L Sinsheimer
Journal:  J Mol Biol       Date:  1969-02-14       Impact factor: 5.469

2.  Properties of the growing point region in the bacterial chromosome.

Authors:  D W Smith; P C Hanawalt
Journal:  Biochim Biophys Acta       Date:  1967-12-19

3.  Use of Brij lysis as a general method to prepare polyribosomes from Escherichia coli.

Authors:  G N Godson; R L Sinsheimer
Journal:  Biochim Biophys Acta       Date:  1967-12-19

4.  The process of infection with bacteriophage phiX174. XXVI. Transfer of the parental DNA of bacteriophage phiX174 into progeny bacteriophage particles.

Authors:  R Knippers; W O Salivar; J E Newbold; R L Sinsheimer
Journal:  J Mol Biol       Date:  1969-02-14       Impact factor: 5.469

5.  The process of infection with bacteriophage phi-X174. IV. Replication of the viral DNA in a synchronized infection.

Authors:  D T Denhardt; R L Sinsheimer
Journal:  J Mol Biol       Date:  1965-07       Impact factor: 5.469

6.  The process of infection with bacteriophage phi-X174. 3. Phage maturation and lysis after synchronized infection.

Authors:  D T Denhardt; R L Sinsheimer
Journal:  J Mol Biol       Date:  1965-07       Impact factor: 5.469

7.  Intracellular location and number of replicating parental DNA molecules of bacteriophages lambda and phi-X174.

Authors:  W O Salivar; R L Sinsheimer
Journal:  J Mol Biol       Date:  1969-04-14       Impact factor: 5.469

8.  The process of infection with bacteriophage phi-X174 VII. Ultracentrifugal analysis of the replicative form.

Authors:  A Burton; R L Sinsheimer
Journal:  J Mol Biol       Date:  1965-12       Impact factor: 5.469

9.  Some factors which influence the replication of the replicative form of bacteriophage OX174.

Authors:  A B Stone
Journal:  Biochem Biophys Res Commun       Date:  1967-02-08       Impact factor: 3.575

10.  Allomorphic forms of bacteriophage phiX-174 replicative DNA.

Authors:  T F Roth; M Hayashi
Journal:  Science       Date:  1966-11-04       Impact factor: 47.728

View more
  2 in total

1.  Association of replicative T4 deoxyribonucleic acid and bacterial membranes.

Authors:  R C Miller
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

2.  Replicative intermediates of bacteriophage T7 deoxyribonucleic acid.

Authors:  M S Center
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.